WallStreetZen

NYSE: PFE
Pfizer Inc Stock

PFE Price
$37.28
Fair Value Price
N/A
Market Cap
$207.16B
52 Week Low
$27.88
52 Week High
$43.08
P/E
23.9x
P/B
3.17x
P/S
4.12x
PEG
0.91x
Dividend Yield
4.02%
Revenue
$48.65B
Earnings
$8.69B
Gross Margin
79.9%
Operating Margin
17.41%
Profit Margin
17.9%
Debt to Equity
1.74
Operating Cash Flow
$13B
Beta
0.71
Next Earnings
Feb 2, 2021
Ex-Dividend
Jan 28, 2021
Next Dividend
Mar 5, 2021

Zen Score

High
Medium
Low
46
Industry average

Reasons for this score

PFE ($37.28) is trading below its intrinsic value of $154.81, according to Benjamin Graham's Formula from Chapter 14 of "The Intelligent Investor"
Valuation
PFE is good value based on its earnings relative to its share price (23.9x), compared to the US market average 31.52x)
Valuation
PFE is good value based on its earnings relative to its share price (23.9x), compared to the US Drug Manufacturers - General industry average (-5.79x)
Valuation

1 of 13

PFE News

Valuation

PFE price to earnings (PE)

For valuing profitable companies with steady earnings
Company
23.9x
Industry
-5.79x
Market
31.52x
PFE is good value based on its earnings relative to its share price (23.9x), compared to the US market average 31.52x)
Valuation
PFE is good value based on its earnings relative to its share price (23.9x), compared to the US Drug Manufacturers - General industry average (-5.79x)
Valuation

PFE price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
3.17x
Industry
9.92x
Market
56.65x
PFE is good value based on its book value relative to its share price (3.17x), compared to the US market average (56.65x)
Valuation
PFE is good value based on its book value relative to its share price (3.17x), compared to the US Drug Manufacturers - General industry average (9.92x)
Valuation

PFE price to earnings growth (PEG)

For valuing profitable companies with growth potential
PFE is good value based on it's Price to Earnings and rate of earnings growth, measured by PEG ratio (0.91x)
Valuation

PFE's financial health

Profit margin

Revenue
$12.1B
Net Income
$2.2B
Profit Margin
18.1%
PFE's Earnings (EBIT) of $8.47B can safely cover interest payments on company debt ($63.15B)
Financials
PFE's profit margin has decreased (-12.7%) in the last year from (30.6%) to (17.9%)
Financials

Assets to liabilities

Assets
$179.0B
Liabilities
$113.5B
Debt to equity
0.97
PFE's short-term assets ($47.74B) exceed its short-term liabilities ($34.15B)
Financials
PFE's long-term liabilities ($79.33B) exceed its short-term assets ($47.74B)
Financials
PFE's debt has increased relative to shareholder equity (1.74), over the past 5 years ago (1.55)
Financials
PFE's debt to equity ratio (1.74) is considered high
Financials

Cash flow

Operating
$2.1B
Investing
$481.0M
Financing
-$2.8B
PFE's operating cash flow ($12.55B) may not be sufficient to safely service the company's debt ($63.15B)
Financials

Pfizer Stock FAQ

What is Pfizer's quote symbol?

(NYSE: PFE) Pfizer trades on the NYSE under the ticker symbol PFE. Pfizer stock quotes can also be displayed as NYSE: PFE.

How much is Pfizer's stock price per share?

(NYSE: PFE) Pfizer stock price per share is $37.28 today (as of Jan 25, 2021).

What is the 52 week high and low for Pfizer (NYSE: PFE)?

(NYSE: PFE) Pfizer's 52-week high was $43.08, and its 52-week low was $27.88. It is currently -13.46% from its 52-week high and 33.72% from its 52-week low.

What is Pfizer's Market Cap?

(NYSE: PFE) Pfizer's market cap is $207.16B, as of Jan 27, 2021.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Pfizer's market cap is calculated by multiplying PFE's current stock price of $37.28 by PFE's total outstanding shares of 5,556,879,807.

How much is Pfizer stock worth today?

(NYSE: PFE) Pfizer currently has 5,556,879,807 outstanding shares. With Pfizer stock trading at $37.28 per share, the total value of Pfizer stock (market capitalization) is $207.16B.

Pfizer stock was originally listed at a price of $24.85 in Dec 31, 1997. If you had invested in Pfizer stock at $24.85, your return over the last 23 years would have been 50%, for an annualized return of 1.78%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Heap | Mobile and Web Analytics